MacGrogan G - Search Results

1

Correction: CD95L Cell Surface Cleavage Triggers a Prometastatic Signaling Pathway in Triple-Negative Breast Cancer.

Malleter M, Tauzin S, Bessede A, Castellano R, Goubard A, Godey F, Levêque J, Jézéquel P, Campion L, Campone M, Ducret T, MacGrogan G, Debure L, Collette Y, Vacher P, Legembre P. Malleter M, et al. Among authors: macgrogan g. Cancer Res. 2020 Feb 1;80(3):639. doi: 10.1158/0008-5472.CAN-19-3636. Cancer Res. 2020. PMID: 32015158 No abstract available.

2

CD95L cell surface cleavage triggers a prometastatic signaling pathway in triple-negative breast cancer.

Malleter M, Tauzin S, Bessede A, Castellano R, Goubard A, Godey F, Levêque J, Jézéquel P, Campion L, Campone M, Ducret T, MacGrogan G, Debure L, Collette Y, Vacher P, Legembre P. Malleter M, et al. Among authors: macgrogan g. Cancer Res. 2013 Nov 15;73(22):6711-21. doi: 10.1158/0008-5472.CAN-13-1794. Epub 2013 Sep 26. Cancer Res. 2013. PMID: 24072745

3

Patterns of genomic change in residual disease after neoadjuvant chemotherapy for estrogen receptor-positive and HER2-negative breast cancer.

Chatzipli A, Bonnefoi H, MacGrogan G, Sentis J, Cameron D, Poncet C; EORTC 10994/BIG 1-00 Consortium; Iggo R. Chatzipli A, et al. Among authors: macgrogan g. Br J Cancer. 2021 Nov;125(10):1356-1364. doi: 10.1038/s41416-021-01526-3. Epub 2021 Sep 3. Br J Cancer. 2021. PMID: 34480095 Free PMC article. Clinical Trial.

4

Accumulation of an endogenous tryptophan-derived metabolite in colorectal and breast cancers.

Puccetti P, Fallarino F, Italiano A, Soubeyran I, MacGrogan G, Debled M, Velasco V, Bodet D, Eimer S, Veldhoen M, Prendergast GC, Platten M, Bessede A, Guillemin GJ. Puccetti P, et al. Among authors: macgrogan g. PLoS One. 2015 Apr 16;10(4):e0122046. doi: 10.1371/journal.pone.0122046. eCollection 2015. PLoS One. 2015. PMID: 25881064 Free PMC article.

5

Residual cancer burden index and tumor-infiltrating lymphocyte subtypes in triple-negative breast cancer after neoadjuvant chemotherapy.

Pinard C, Debled M, Ben Rejeb H, Velasco V, Tunon de Lara C, Hoppe S, Richard E, Brouste V, Bonnefoi H, MacGrogan G. Pinard C, et al. Among authors: macgrogan g. Breast Cancer Res Treat. 2020 Jan;179(1):11-23. doi: 10.1007/s10549-019-05437-z. Epub 2019 Sep 16. Breast Cancer Res Treat. 2020. PMID: 31529299

6

Enhancing Abiraterone Acetate Efficacy in Androgen Receptor-positive Triple-negative Breast Cancer: Chk1 as a Potential Target.

Grellety T, Callens C, Richard E, Briaux A, Vélasco V, Pulido M, Gonçalves A, Gestraud P, MacGrogan G, Bonnefoi H, Cardinaud B. Grellety T, et al. Among authors: macgrogan g. Clin Cancer Res. 2019 Jan 15;25(2):856-867. doi: 10.1158/1078-0432.CCR-18-1469. Epub 2018 Oct 23. Clin Cancer Res. 2019. PMID: 30352905

7

Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer?

Ragage F, Debled M, MacGrogan G, Brouste V, Desrousseaux M, Soubeyran I, de Lara CT, Mauriac L, de Mascarel I. Ragage F, et al. Among authors: macgrogan g. Cancer. 2010 Jul 1;116(13):3093-101. doi: 10.1002/cncr.25137. Cancer. 2010. PMID: 20564641 Free article.

8

Immunohistochemically detected lymph node metastases from breast carcinoma: practical considerations about the new American Joint Committee on Cancer classification.

de Mascarel I, Soubeyran I, MacGrogan G, Picot V, Mathoulin-Pélissier S. de Mascarel I, et al. Among authors: macgrogan g. Cancer. 2005 Apr 1;103(7):1319-22. doi: 10.1002/cncr.20937. Cancer. 2005. PMID: 15719436 Free article.

9

Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations.

Banneau G, Guedj M, MacGrogan G, de Mascarel I, Velasco V, Schiappa R, Bonadona V, David A, Dugast C, Gilbert-Dussardier B, Ingster O, Vabres P, Caux F, de Reynies A, Iggo R, Sevenet N, Bonnet F, Longy M. Banneau G, et al. Among authors: macgrogan g. Breast Cancer Res. 2010;12(4):R63. doi: 10.1186/bcr2626. Epub 2010 Aug 16. Breast Cancer Res. 2010. PMID: 20712882 Free PMC article.

10

PTEN alterations in sporadic and BRCA1-associated triple negative breast carcinomas.

Jones N, Gros A, Velasco V, Dapremont V, Brouste V, Gastaldello B, Debled M, Tunon de Lara C, Bonnet F, Barouk-Simonet E, Bubien V, Venat L, MacGrogan G, Longy M, Sevenet N. Jones N, et al. Among authors: macgrogan g. Cancer Genet. 2022 Jun;264-265:8-15. doi: 10.1016/j.cancergen.2022.02.008. Epub 2022 Feb 25. Cancer Genet. 2022. PMID: 35263698

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

228 results

Search Page

Filters